PATENT CLAIM ANALYSIS

Application Number: 15879826
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-08
Patent Classification: ["544", "323000"]

Abstract:
The various examples presented herein are directed to compounds of the Formula: wherein R 1 -R 5  are defined herein, and uses of such compounds to, among other things, inhibit an immune response in a subject.

Claim (Index 7):
The compound of  claim 6 , wherein:\n R 4  is (C 1-20 )-alkyl-NR 6 R 7 , wherein R 6  and R 7 , together with the nitrogen to which they are attached from a (C 2 -C 20 )-heterocyclyl group.

Metadata:
- Claim Count in Document: 26.0
- Percentile: 86.0
- Lexical Diversity: 1.20588
- Patent Class: 544.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13509646', '13939232', '14670421', '15359871', '12728153']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7501577201383549
- 35 USC 102 Novelty (BERT): 0.4970153294349643
- Combined Prediction Score: 0.7248434810680159
- Mean Citation Score: 214.498996
- Max Citation Score: 218.93631
- Similarity Product: 156.20415894655287

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test